BlackRock Institutional Trust’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$54.3M Buy
1,467,624
+13,057
+0.9% +$467K 0.01% 1295
2016
Q3
$50.4M Buy
1,454,567
+56,792
+4% +$1.99M 0.01% 1290
2016
Q2
$45.5M Buy
1,397,775
+26,383
+2% +$808K 0.01% 1296
2016
Q1
$39.4M Buy
1,371,392
+28,541
+2% +$760K 0.01% 1379
2015
Q4
$44.9M Buy
1,342,851
+32,015
+2% +$995K 0.01% 1310
2015
Q3
$37.3M Sell
1,310,836
-344,471
-21% -$12M 0.01% 1415
2015
Q2
$67M Sell
1,655,307
-338,309
-17% -$15.2M 0.01% 1133
2015
Q1
$98.1M Buy
1,993,616
+101,703
+5% +$4.71M 0.02% 935
2014
Q4
$86M Buy
+1,891,913
New +$74.3M 0.01% 963

Other funds holding AVNS

BlackRock Institutional Trust's AVNS Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Avanos Medical (AVNS) stake by 0.9% in Q4 2016, buying an estimated $467K and bringing the position to 1,467,624 shares worth $54.3M. The position accounts for 0.01% of the portfolio, ranked #1295.

BlackRock Institutional Trust first reported a position in AVNS in Q4 2014 and has held it in 9 quarters since. The position peaked at $98.1M in Q1 2015. 359 funds tracked by Wall St. Rank hold AVNS as of Q4 2016.

  • BlackRock Institutional Trust held 1,467,624 shares of Avanos Medical worth $54.3M as of Q4 2016.
  • BlackRock Institutional Trust bought 13,057 Avanos Medical shares in Q4 2016, an estimated $467K.
  • Avanos Medical made up 0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #1295 holding.
  • BlackRock Institutional Trust first reported a position in Avanos Medical in Q4 2014 and has held it in 9 quarters since.
  • BlackRock Institutional Trust's Avanos Medical position peaked at $98.1M in Q1 2015.
  • 359 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.